Related references
Note: Only part of the references are listed.
Review
Pharmacology & Pharmacy
Abdallah Ladaycia et al.
Summary: Nanomedicine has attracted significant attention in cancer treatment and diagnosis studies, but only a few have successfully passed clinical trials. The human microbiota plays a crucial role in cancer development, and utilizing nanoparticles to modulate the microbiota may improve the translation of nanomedicine from preclinical to clinical trials. Co-culture models of bacteria and cancer cells, as well as animal cancer-microbiota models, offer a more representative tumor microenvironment for testing nanomedicine efficacy in cancer treatment. These models provide a closer representation of human cancer and may facilitate the transition from preclinical to clinical studies for nanomedicine efficacy.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Lisa A. Mestrinho et al.
Summary: Spontaneous tumors in pet dogs can serve as a valuable model to bridge the gap between preclinical models and human clinical trials, due to their similar cellular, molecular, and genetic characteristics with humans. This model can accelerate the translation of preclinical studies to clinical trials, benefiting both species.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Takahiro Yamazaki et al.
Summary: Autophagy is crucial for cellular homeostasis in eukaryotic cells, benefiting both normal and malignant cells. It plays a key role in the immunological control of malignant transformation, tumor progression, and response to therapy. However, the effects of autophagy activation or inhibition on tumor growth and therapeutic responses are context-dependent, highlighting the complex interplay between autophagy and immuno-oncology in cancer.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
M. Masmudi-Martin et al.
Summary: Brain metastasis is a unique entity in oncology with specific biological characteristics and different pharmacological approaches. Despite pre-clinical evidence demonstrating vulnerabilities, many clinical trials have excluded patients with brain metastasis. Emerging trends and unsolved issues will shape the study of experimental brain metastasis in the future.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Michal Caspi et al.
Summary: The Wnt pathway plays a crucial role in regulating embryogenic developmental processes and tissue homeostasis via beta-catenin. Dysregulation of this pathway has been implicated in carcinogenesis, particularly in colorectal cancer. While the Wnt cascade is an attractive target for therapeutic intervention against CRC, its complexity and challenges need to be addressed for effective treatment.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Carina Peres et al.
Summary: Targeted immunotherapies have revolutionized cancer treatment, but tumor heterogeneity and immunosuppression mechanisms have hindered the success of cancer vaccines. Nanotechnology offers promising solutions, but the selection of appropriate preclinical models is crucial.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Sabina Pozzi et al.
Summary: Three-dimensional cancer models have been developed to study a wide range of biological applications, including cell signaling pathways, metastatic cascade steps, and personalized medicine, in vitro. By combining different cell types and external stimuli, these models can more accurately mimic the biology and pathophysiology of in vivo tumors.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Talia Golan et al.
Summary: PDAC is a dismal disease with poor overall survival rates, often diagnosed at advanced stages. The most clinically meaningful subtype from PDAC genomic classification has unstable genomes and inactivation of DNA damage repair genes. Treatment with olaparib has been approved for some advanced PDAC patients with BRCA mutations, but resistance remains a challenge.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
David Olmeda et al.
Summary: Imaging of the lymphatic vasculature is crucial in understanding various diseases, particularly in cancer. Activation of lymphatic endothelial cells plays a key role in therapeutic strategies. Current research focuses on visualizing the lymphatic system through imaging technologies and targeting it with drugs.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Flavia Castro et al.
Summary: Colorectal cancer is a heterogeneous and molecularly complex disease that requires novel therapeutic approaches. Traditional 2D models and animal models have limitations, while multicellular 3D systems are emerging as a promising tool in cancer research.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Paz Boix-Montesinos et al.
Summary: Despite recent advancements in nanomedicine for breast cancer treatment and promising results in pre-clinical models, clinical trials often face challenges. Innovative cell culture strategies and consideration of critical parameters for in vivo evaluation are essential to improve the clinical translation efficiency of nanomedicines in breast cancer treatment.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Tengku Ibrahim Maulana et al.
Summary: The progress in cancer immunotherapy is hindered by obstacles, notably the lack of representative nonclinical models that can predict clinical outcomes. The emergence of immunocompetent Cancer-on-Chip models presents novel opportunities to address this challenge.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
Review
Pharmacology & Pharmacy
Marcel A. Heinrich et al.
Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type with a complex tumor microenvironment, making treatment challenging. This article provides an overview of recent developments in in vitro and in vivo models aiming to mimic the complexity of PDAC, highlighting the lack of biologically relevant models that resemble the complexity of PDAC.
ADVANCED DRUG DELIVERY REVIEWS
(2021)
